New Delhi, Aug 2 (UNI) A team of scientists from the Institute of Nano Science & Technology (INST), an autonomous institute under the Department of Science & Technology, has developed nanorods from the nonsteroidal anti-inflammatory drug (NSAID) Aspirin, a popular medication used to reduce pain and fever, found to be an effective non–invasive small molecule-based nanotherapeutics against cataract.
This easy to use and low-cost alternative nonsurgical treatment method will benefit patients in developing countries who cannot access expensive cataract treatments and surgeries. Their research, published in the Journal of Materials Chemistry B, says it could help prevent cataracts in an economical and less complicated way.
Cataract are a major form of blindness that occurs when the structure of crystallin proteins of the lens in the eyes deteriorate, causing damaged or disorganised proteins to form a milky blue or brown layer and affecting lens transparency. Prevention of the formation of these aggregates and their destruction in the early stage of disease progression is a major treatment strategy for cataracts.